"Designing Growth Strategies is in our DNA"
Artificial Intelligence (AI) is a branch of computer science that aims to create machines capable of performing tasks that would typically require human intelligence. These tasks include learning, problem-solving, perception, and decision-making. AI systems can interpret and analyze data, adapt to new inputs, and make decisions without explicit programming.
The deployment of Artificial Intelligence (AI) in mental health involves the usage of computational technologies to enhance the understanding, diagnosis, and treatment of mental health disorders. It analyzes data from various sources, such as electronic health records (EHR) and wearable devices, to identify biomarkers and improve the accuracy of diagnosis. AI systems can determine personalized treatments, enhance access to mental healthcare, and support clinical decision-making by analyzing large datasets rapidly. Additionally, AI supports mental health services, increases workplace efficiency, and promotes wellness through empathetic, text-based, conversational mobile apps, benefiting users with depression and other conditions.
The integration of artificial intelligence (AI) in mental health care enhances the diagnosis and treatment due to its capability to evaluate people's speech, behaviors, and social interactions with the use of machine learning (ML) algorithms. This enables more accurate diagnosis of mental health conditions, resulting in an increased adoption of AI-powered solutions. Therefore, the growth of the market is primarily attributed to the rising acceptance and adoption of AI technologies in mental health care. This high adoption is expected to be fueled by the rising prevalence of mental health disorders and the need for more effective and efficient mental health care solutions.
These factors are expected to increase the demand for AI-based solutions, driving market growth. Moreover, the increase in the number of studies that discover or advance the use of artificial intelligence (AI) in mental health is also anticipated to propel market expansion over the coming years.
Such developments are expected to increase the availability of different technologies used for AI in mental health, propelling the market growth.
The COVID-19 pandemic had a significant impact on the adoption of AI in mental health. The pandemic led to a preferential shift in the delivery of mental health services toward the online counseling due to the closure of several healthcare facilities, thereby providing an opportunity for AI in mental health.
The report covers the following key insights:
By Technology | By Application | By End-user | By Geography |
|
|
|
|
Based on technology, the machine learning & deep learning segment is expected to hold a significant share of the global AI in the mental health market during the forecast period. The AI technologies, including machine learning & deep learning, propose an objective and evidence-based approach to improve the accuracy of mental health diagnoses. This advantage is anticipated to boost the adoption of AI-based solutions for mental health during the projection period.
These significant outcomes of machine learning & deep learning are expected to boost their utilization of AI-based solutions for mental health, thereby spurring segmental growth over the upcoming years.
On the other hand, natural language processing (NLP) is expected to witness substantial growth prospects during the forecast period. Natural language processing (NLP) provides several advantages in the simulation of human conversations via a chatbot and creating and understanding clinical documentation. This increases the demand for natural language processing in AI-powered solutions and expands their availability throughout, which is expected to boost the segmental growth.
North America is anticipated to hold a significant share of the AI in the mental health market during the forecast period. The increasing investments by regional investors to bring AI-powered mental health support to the region are expected to fuel the availability of AI-powered tools by global players in the region. This increasing availability of AI-powered tools enhances the diagnosis and treatment outcomes for mental health in the region, increasing their utilization, which is expected to boost the regional market growth.
Asia Pacific is projected to expand at a substantial CAGR over the forthcoming years. AI-powered tools such as chatbots help in the diagnosis and treatment of mental illnesses with the interpretation of non-verbal signs, including posture, facial expression, or gestures, to understand a patient’s emotional state and choose proper words to relieve stress and anxiety. This advantage of AI in treating mental illnesses increases their adoption in the diagnosis and treatment of several mental illnesses. Therefore, the increasing burden of mental disorders such as anxiety and depression has been fueling the demand for AI-driven tools for disease management.
The report includes the profiles of key players such as Woebot Health, Wysa Ltd, HEADSPACE HEALTH, Cognoa, Inc., New Life Solution, Inc., Talkspace, Youper Inc., Limbic, and Quartet.
US +1 833 909 2966 ( Toll Free )